§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US4130641A Expired / Lapsed US ⏱️ 0.0 years remaining

Induction of interferon production by modified nucleic acid complexes

Assignee: Individual
•
Filing: 1976-09-24
•
Granted: 1978-12-19
•
Expires: 1996-09-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to the induction of interferon production in the cells of living organisms, including human beings. According to the invention, nucleic acid complexes, such as the polyriboinosinate and polycytidylate complex (rI n ·rC n ), are modified to yield unpaired bases, (uracil or guanine) along the polycytidylate strand which render the complexes more readily hydrolyzable by nucleases present in living cells. The modified complexes retain their ability to stimulate interferon release by the cells but are rendered more vulnerable to destruction within the cells, the modified complexes being significantly less toxic than the original complexes. In addition, polyinosinate strand now has been prepared to contain 5-16% 2'-O-methyl inosinate residues, designated as (rI 5-20 , 2'-MeI) n . The new complex (rI 5-20 , 2'-MeI) n ·rC n , exhibits 100-fold more activity than rI n ·rC n as an interferon inducer in human cells.

Inventors

  • 👤 Paul O. P. Ts'o
  • 👤 William A. Carter

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:05
CPC Classifications
C; C07; C07H; C07H21/00; Y; Y10; Y10S; Y10S435/00; Y10S435/811

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 77 words
A method for inducing interferon production in living animal cells in culture without toxic effects to the cells, comprising the step of: administering an effective amount of a double-stranded, helical RNA molecular species having at least one chemical site which is readily hydrolyzed by nucleases, said site being created by the incorporation into the RNA strand of an unpaired nucleotide such as guanine nucleotide and uridine nucleotide wherein said nucleotide contains a 3'-connected to 5'-phosphoryl diester linkage.
Claim 2
Independent Claim 77 words
A method for inducing interferon production in living animal cells in culture without toxic effects to the cells, comprising the step of: administering an effective amount of a double-stranded, helical RNA molecular species having at least one chemical site which is readily hydrolyzed by nucleases, said site being created by the incorporation into the RNA strand of an unpaired nucleotide such as guanine nucleotide and uridine nucleotide wherein said nucleotide contains a 3'-connected to 5'-phosphoryl diester linkage.
Claim 3
Dependent Claim 17 words
The method of claim 1 wherein said helical RNA molecular species is rI n ·rC n .
Claim 4
Dependent Claim 20 words
The method of claim 1 wherein said molecular species comprises rI n ·rC n having a methyl group bonded thereto.
Claim 5
Dependent Claim 40 words
The method of claim 1 wherein said molecular species is selected from the group consisting of the (rI 5-20 ,mI) n ·rC n complexes wherein m is the 2'-O-Methyl ribosyl group and the polyinosinate strand consists of 5-16% 2'-O-Methylinosine residue.
Claim 6
Independent Claim 57 words
A method of therapeutically inducing interferon production in a human in need of such therapy, which method comprises: administering to the human an effective amount of a complex selected from the group consisting of poly(I)·poly(C n ,U) and poly(I)·poly(C n ,G), wherein n is an integer having a value of from 4 to 29 to induce interferon.
Claim 7
Independent Claim 57 words
A method of therapeutically inducing interferon production in a human in need of such therapy, which method comprises: administering to the human an effective amount of a complex selected from the group consisting of poly(I)·poly(C n ,U) and poly(I)·poly(C n ,G), wherein n is an integer having a value of from 4 to 29 to induce interferon.
Claim 8
Dependent Claim 13 words
A method as in claim 5 wherein the complex is poly(I)·poly(C 4 ,U).
Claim 9
Dependent Claim 13 words
A method as in claim 5, wherein the complex is poly(I)·poly(C 7 ,U).
Claim 10
Dependent Claim 13 words
A method as in claim 5, wherein the complex is poly(I)·poly(C 13 ,U).
Claim 11
Dependent Claim 13 words
A method as in claim 5, wherein the complex is poly(I)·poly(C 22 ,U).
Claim 12
Dependent Claim 13 words
A method as in claim 5, wherein the complex is poly(I)·poly(C 20 ,G).
Claim 13
Dependent Claim 13 words
A method as in claim 5, wherein the complex is poly(I)·poly(C 29 ,G).

References Cited (Backward Citations)

US3980776A Cited
US3843629A Cited
US3845033A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-12-18 1982-06-19 1982-12-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-12-18 1986-06-19 1986-12-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-12-18 1990-06-19 1990-12-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag